Atlas Trials

High-risk Non-Muscle Invasive Bladder Cancer

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-risk Non-Muscle Invasive Bladder Cancer

RecordFirmDate
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676) (NCT03711032)Merck Sharp & Dohme LLC2018-12-24
Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI® (NCT03191578)Archivel Farma S.L.2017-06-16

Track High-risk Non-Muscle Invasive Bladder Cancer automatically

Every clearance here is in the API, with alerts when new ones post.